Immunotherapy and molecularly targeted treatment of breast and gastrointestinal tumors

Abstract

Predictive testing of breast and gastrointestinal cancers is one way of precision medicine based on the identification of molecular profile and targetable biomarkers. Specific "tailor-made" target treatment has significantly enriched the healing armamentarium of these solid malignancies as well.

Drugs focused on specific goals are gradually being implemented in clinical practice and their use brings significant improvements in therapeutic results.

Keywords

• predictive testing
• targetable mutations
• biomarkers
• breast cancer
• gastrointestinal tumors